Active Ingredient History
Organization | Org Type | FDA approvals | Clinical Trials involvement | Org ID | Force Sort |
---|
Organization | Org Type | FDA approvals | Clinical Trials involvement | Org ID | Force Sort |
---|
Alzheimer Disease (Phase 1)
Brain Neoplasms (Phase 2)
Breast Neoplasms (Phase 1)
Carotid Arteries (Phase 1)
Carotid Stenosis (Phase 2)
Cognitive Dysfunction (Phase 1)
Diagnostic Imaging (Phase 1)
Epilepsy, Post-Traumatic (Phase 1)
Fatigue Syndrome, Chronic (Phase 1)
Fibromyalgia (Phase 1)
Healthy Volunteers (Phase 1)
Idiopathic Pulmonary Fibrosis (Phase 1)
Medulloblastoma (Phase 2)
Memory Disorders (Phase 1)
Multiple Sclerosis (Phase 1)
Myocardial Infarction (Phase 1)
Ovarian Neoplasms (Phase 1)
Parkinson Disease (Phase 2)
Severe acute respiratory syndrome-related coronavirus (Early Phase 1)
Triple Negative Breast Neoplasms (Phase 2)
Trial | Phase | Start Date | Organizations | Indications |
---|
Feedback
Data collection and curation is an ongoing process for CDEK - if you notice any information here to be missing or incorrect, please let us know! When possible, please include a source URL (we verify all data prior to inclusion).
Report issue